Skip to main content

Pharmacy

By Susan Morse | 03:19 pm | August 23, 2017
Interventions lead to fewer prescriptions, less opioid consumption by aggressively limiting opioid dose and duration of therapy at the initial first fill.
By Beth Jones Sanborn | 03:52 pm | July 27, 2017
Settlement resolves allegations that Celgene promoted cancer drugs Thalomid, Revlimid for uses not approved by the FDA.
By Susan Morse | 02:22 pm | July 24, 2017
Roughly 45 percent of urgent care facility visits by Cigna members could be conducted at retail healthcare clinics, insurer says.
By Kaiser Health News | 09:47 am | July 24, 2017
Congressional donations from pharma PACs rose 11 percent in this year's first quarter, compared to first quarter 2015, Kaiser analysis shows.
By Beth Jones Sanborn | 11:12 am | July 10, 2017
The agreement settles allegations that Walmart failed to confirm and document the necessary diagnoses for Code 1 drugs.
By Jeff Lagasse | 01:56 pm | July 07, 2017
One of the main culprits is the "buy-and-bill" reimbursement model for infused therapies.
By Beth Jones Sanborn | 12:58 pm | June 19, 2017
Expert Julie Hurley will address pitfalls in "Securing and Illuminating the Pharmaceutical Supply Chain" webinar Wednesday.
By Kaiser Health News | 09:53 am | June 19, 2017
Documents reveal behind-the-scenes discussions influenced by pharmaceutical industry, led by former Gilead lobbyist Joe Grogan.
By Jeff Lagasse | 10:22 am | June 13, 2017
Some high-priced drugs like Sovaldi, a hepatitis C drug which initially cost $84,000, involved no rebates until other competitors came to market.
By Kaiser Health News | 09:53 am | June 08, 2017
Costs for prescription drugs have been rising faster than those for any other health segment, marked by high-profile cases like EpiPen and Daraprim.